How to Make Your Case to Attend Breakthrough 2025: AI in Action
Are you eager to attend Breakthrough 2025 this March in Zurich but need to secure approval from your manager or team?
Are you eager to attend Breakthrough 2025 this March in Zurich but need to secure approval from your manager or team?
In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.
Steve Gens previews some of the new research findings he’ll come armed with to a discussion panel on the future of Regulatory operations in an AI automation context.
Breakthrough 2025 is set to be a pivotal event for safety, regulatory, and life sciences professionals.
In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
In the ever-evolving pharmacovigilance landscape , embracing automation and AI has become a strategic necessity for global pharmaceutical companies.
A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved